Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Merck and ChemLex to explore AI and automation collaboration for faster, more efficient drug and material development.
Merck and ChemLex have signed a non-binding Memorandum of Understanding to explore a collaboration focused on advancing automated chemistry and AI-driven synthesis.
The partnership aims to enhance the speed, efficiency, and reproducibility of early-stage research in life sciences and electronics by combining Merck’s scientific expertise with ChemLex’s automated platform.
Key areas include automated synthesis, reaction optimization, and high-throughput experimentation, with initial efforts targeting high-impact programs.
Both companies emphasize data-rich, scalable innovation and digital transformation, planning further discussions to define next steps.
Merck y ChemLex explorarán la colaboración en IA y automatización para un desarrollo de medicamentos y materiales más rápido y eficiente.